These drugs can cross the BBB, reduce insulin resistance, stabilize mitochondrial function, and increase the survival and functional state of neurons
In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost ~28.7% of body weight (~71 lbs at 68 weeks) and saw substantial improvements in pain and function: WOMAC pain scores reduced by 4.5 points (75.8%) Meaningful gains in physical function, with many patients essentially free of knee pain by study end If these results are confirmed in broader use, were not just talking about weight loss drugs anymorewere talking about disease-modifying therapies that simultaneously target obesity, pain, mobility, and downstream CV risk
Rota, M., Antolini, L
Shaking creates foam air bubbles trapped against peptide molecules which can denature the peptide at the air-liquid interface
Serious complications are rare, and your healthcare provider can help tailor your dosing schedule to minimize risks
GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1
